VIN 2 of Usual Type
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) (NCT06075264) | Frantz Viral Therapeutics, LLC | 2023-12-06 |
Track VIN 2 of Usual Type automatically
Every clearance here is in the API, with alerts when new ones post.